GT Medical Technologies is a medical device company with the purpose of “Improving the Lives of Patients with Brain Tumors”. Our GammaTile™ Therapy uses an implantable collagen tile with embedded radio isotope. Over 100 patients (most with recurrent brain tumors) have been treated with GammaTile™ Therapy with impressive results compared to the current standard of care for these patients. The company anticipates FDA clearance in mid-2018 with a limited market release in Q4, 2018, with a goal of establishing the new standard of care.
Rosenman Innovators, Founders Pledge, MedTech Venture Partners